(+)-4-PROPYL-9-HYDROXYNAPHTHOXAZINE (PHNO), A NEW DOPAMINOMIMETIC, IN TREATMENT OF PARKINSONISM
- 30 November 1985
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 326 (8468), 1330-1331
- https://doi.org/10.1016/s0140-6736(85)92627-3
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- PHARMACOLOGIC PROFILE OF A NOVEL POTENT DIRECT-ACTING DOPAMINE AGONIST, "(+)-4-PROPYL-9-HYDROXYNAPHTHOXAZINE [(+)-PHNO]1984
- Dopamine Receptor Agonists in the Treatment of Basal Ganglia DisordersSeminars in Neurology, 1982
- BROMOCRIPTINE ASSOCIATED WITH A PERIPHERAL DOPAMINE BLOCKING AGENT IN TREATMENT OF PARKINSON'S DISEASEThe Lancet, 1979
- ParkinsonismNeurology, 1967